Literature DB >> 34889390

Unexplained arterial thrombosis: approach to diagnosis and treatment.

Jori E May1, Stephan Moll2.   

Abstract

Arterial thrombotic events in younger patients without a readily apparent etiology present significant diagnostic and management challenges. We present a structured approach to diagnosis with consideration of common causes, including atherosclerosis and embolism, as well as uncommon causes, including medications and substances, vascular and anatomic abnormalities, systemic disorders, and thrombophilias. We highlight areas of management that have evolved within the past 5 years, including the use of dual-pathway inhibition in atherosclerotic disease, antithrombotic therapy selection in embolic stroke of undetermined source and left ventricular thrombus, the role of closure of patent foramen ovale for secondary stroke prevention, and the thrombotic potential of coronavirus disease 2019 infection and vaccination. We conclude with a representative case to illustrate the application of the diagnostic framework and discuss the importance of consideration of bleeding risk and patient preference in determining the appropriate management plan.
Copyright © 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34889390      PMCID: PMC8791102          DOI: 10.1182/hematology.2021000235

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  52 in total

1.  An approach to diagnosis and initial management of systemic vasculitis.

Authors:  D W Roane; D R Griger
Journal:  Am Fam Physician       Date:  1999-10-01       Impact factor: 3.292

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Arterial thromboembolic events preceding the diagnosis of cancer in older persons.

Authors:  Babak B Navi; Anne S Reiner; Hooman Kamel; Costantino Iadecola; Peter M Okin; Scott T Tagawa; Katherine S Panageas; Lisa M DeAngelis
Journal:  Blood       Date:  2018-12-21       Impact factor: 22.113

4.  Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.

Authors:  Florian Moik; Wei-Shin Evelyn Chan; Sarah Wiedemann; Christoph Hoeller; Felix Tuchmann; Marie-Bernadette Aretin; Thorsten Fuereder; Sabine Zöchbauer-Müller; Matthias Preusser; Ingrid Pabinger; Cihan Ay
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

5.  Assessment of Clinical Conditions Associated With Splenic Infarction in Adult Patients.

Authors:  Allan S Brett; Neda Azizzadeh; Emily M Miller; Robert J Collins; Mary B Seegars; Matthew A Marcus
Journal:  JAMA Intern Med       Date:  2020-08-01       Impact factor: 21.873

Review 6.  Vascular disease in cocaine addiction.

Authors:  Keren Bachi; Venkatesh Mani; Devi Jeyachandran; Zahi A Fayad; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Atherosclerosis       Date:  2017-03-14       Impact factor: 5.162

7.  Acute retinal arterial occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2011-05-19       Impact factor: 21.198

Review 8.  Thrombotic Risk from Chemotherapy and Other Cancer Therapies.

Authors:  M D Debbie Jiang; M D Alfred Ian Lee
Journal:  Cancer Treat Res       Date:  2019

Review 9.  Thrombotic complications of erythropoiesis-stimulating agents.

Authors:  Giuseppe Lippi; Massimo Franchini; Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2010-07-14       Impact factor: 4.180

Review 10.  How I assess and manage the risk of bleeding in patients treated for venous thromboembolism.

Authors:  Frederikus A Klok; Menno V Huisman
Journal:  Blood       Date:  2020-03-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.